Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Galectin 3 Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Galectin 3 Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Galectin 3 Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Galectin 3 Market Size Growth Rate by Type
    • 1.4.2 GAL-300
    • 1.4.3 GRMD-03
    • 1.4.4 ANG-4021
    • 1.4.5 KTI
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Galectin 3 Market Size Growth Rate by Application
    • 1.5.2 Liver Cirrhosis
    • 1.5.3 Portal Hypertension
    • 1.5.4 Metastatic Melanoma
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Galectin 3 Market Size, Estimates and Forecasts
    • 2.1.1 Global Galectin 3 Revenue 2015-2026
    • 2.1.2 Global Galectin 3 Sales 2015-2026
  • 2.2 Global Galectin 3, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Galectin 3 Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Galectin 3 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Galectin 3 Competitor Landscape by Players

  • 3.1 Galectin 3 Sales by Manufacturers
    • 3.1.1 Galectin 3 Sales by Manufacturers (2015-2020)
    • 3.1.2 Galectin 3 Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Galectin 3 Revenue by Manufacturers
    • 3.2.1 Galectin 3 Revenue by Manufacturers (2015-2020)
    • 3.2.2 Galectin 3 Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Galectin 3 Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Galectin 3 Revenue in 2019
    • 3.2.5 Global Galectin 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Galectin 3 Price by Manufacturers
  • 3.4 Galectin 3 Manufacturing Base Distribution, Product Types
    • 3.4.1 Galectin 3 Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Galectin 3 Product Type
    • 3.4.3 Date of International Manufacturers Enter into Galectin 3 Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Galectin 3 Market Size by Type (2015-2020)
    • 4.1.1 Global Galectin 3 Sales by Type (2015-2020)
    • 4.1.2 Global Galectin 3 Revenue by Type (2015-2020)
    • 4.1.3 Galectin 3 Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Galectin 3 Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Galectin 3 Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Galectin 3 Revenue Forecast by Type (2021-2026)
    • 4.2.3 Galectin 3 Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Galectin 3 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Galectin 3 Market Size by Application (2015-2020)
    • 5.1.1 Global Galectin 3 Sales by Application (2015-2020)
    • 5.1.2 Global Galectin 3 Revenue by Application (2015-2020)
    • 5.1.3 Galectin 3 Price by Application (2015-2020)
  • 5.2 Galectin 3 Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Galectin 3 Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Galectin 3 Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Galectin 3 Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Galectin 3 by Country
    • 6.1.1 North America Galectin 3 Sales by Country
    • 6.1.2 North America Galectin 3 Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Galectin 3 Market Facts & Figures by Type
  • 6.3 North America Galectin 3 Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Galectin 3 by Country
    • 7.1.1 Europe Galectin 3 Sales by Country
    • 7.1.2 Europe Galectin 3 Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Galectin 3 Market Facts & Figures by Type
  • 7.3 Europe Galectin 3 Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Galectin 3 by Region
    • 8.1.1 Asia Pacific Galectin 3 Sales by Region
    • 8.1.2 Asia Pacific Galectin 3 Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Galectin 3 Market Facts & Figures by Type
  • 8.3 Asia Pacific Galectin 3 Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Galectin 3 by Country
    • 9.1.1 Latin America Galectin 3 Sales by Country
    • 9.1.2 Latin America Galectin 3 Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Galectin 3 Market Facts & Figures by Type
  • 9.3 Central & South America Galectin 3 Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Galectin 3 by Country
    • 10.1.1 Middle East and Africa Galectin 3 Sales by Country
    • 10.1.2 Middle East and Africa Galectin 3 Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Galectin 3 Market Facts & Figures by Type
  • 10.3 Middle East and Africa Galectin 3 Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Angion Biomedica Corp
    • 11.1.1 Angion Biomedica Corp Corporation Information
    • 11.1.2 Angion Biomedica Corp Description and Business Overview
    • 11.1.3 Angion Biomedica Corp Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Angion Biomedica Corp Galectin 3 Products Offered
    • 11.1.5 Angion Biomedica Corp Related Developments
  • 11.2 Bristol-Myers Squibb Company
    • 11.2.1 Bristol-Myers Squibb Company Corporation Information
    • 11.2.2 Bristol-Myers Squibb Company Description and Business Overview
    • 11.2.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Bristol-Myers Squibb Company Galectin 3 Products Offered
    • 11.2.5 Bristol-Myers Squibb Company Related Developments
  • 11.3 Galectin Therapeutics Inc
    • 11.3.1 Galectin Therapeutics Inc Corporation Information
    • 11.3.2 Galectin Therapeutics Inc Description and Business Overview
    • 11.3.3 Galectin Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Galectin Therapeutics Inc Galectin 3 Products Offered
    • 11.3.5 Galectin Therapeutics Inc Related Developments
  • 11.4 GlycoMimetics Inc
    • 11.4.1 GlycoMimetics Inc Corporation Information
    • 11.4.2 GlycoMimetics Inc Description and Business Overview
    • 11.4.3 GlycoMimetics Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 GlycoMimetics Inc Galectin 3 Products Offered
    • 11.4.5 GlycoMimetics Inc Related Developments
  • 11.5 iTeos Therapeutics SA
    • 11.5.1 iTeos Therapeutics SA Corporation Information
    • 11.5.2 iTeos Therapeutics SA Description and Business Overview
    • 11.5.3 iTeos Therapeutics SA Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 iTeos Therapeutics SA Galectin 3 Products Offered
    • 11.5.5 iTeos Therapeutics SA Related Developments
  • 11.6 MandalMed Inc
    • 11.6.1 MandalMed Inc Corporation Information
    • 11.6.2 MandalMed Inc Description and Business Overview
    • 11.6.3 MandalMed Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 MandalMed Inc Galectin 3 Products Offered
    • 11.6.5 MandalMed Inc Related Developments
  • 11.1 Angion Biomedica Corp
    • 11.1.1 Angion Biomedica Corp Corporation Information
    • 11.1.2 Angion Biomedica Corp Description and Business Overview
    • 11.1.3 Angion Biomedica Corp Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Angion Biomedica Corp Galectin 3 Products Offered
    • 11.1.5 Angion Biomedica Corp Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Galectin 3 Market Estimates and Projections by Region
    • 12.1.1 Global Galectin 3 Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Galectin 3 Revenue Forecast by Regions 2021-2026
  • 12.2 North America Galectin 3 Market Size Forecast (2021-2026)
    • 12.2.1 North America: Galectin 3 Sales Forecast (2021-2026)
    • 12.2.2 North America: Galectin 3 Revenue Forecast (2021-2026)
    • 12.2.3 North America: Galectin 3 Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Galectin 3 Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Galectin 3 Sales Forecast (2021-2026)
    • 12.3.2 Europe: Galectin 3 Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Galectin 3 Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Galectin 3 Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Galectin 3 Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Galectin 3 Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Galectin 3 Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Galectin 3 Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Galectin 3 Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Galectin 3 Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Galectin 3 Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Galectin 3 Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Galectin 3 Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Galectin 3 Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Galectin 3 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Galectin 3 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Galectin 3 Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Galectin 3 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Galectin 3 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Galectin 3 market is segmented into
    GAL-300
    GRMD-03
    ANG-4021
    KTI
    Others

    Segment by Application, the Galectin 3 market is segmented into
    Liver Cirrhosis
    Portal Hypertension
    Metastatic Melanoma
    Others

    Regional and Country-level Analysis
    The Galectin 3 market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Galectin 3 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Galectin 3 Market Share Analysis
    Galectin 3 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Galectin 3 business, the date to enter into the Galectin 3 market, Galectin 3 product introduction, recent developments, etc.

    The major vendors covered:
    Angion Biomedica Corp
    Bristol-Myers Squibb Company
    Galectin Therapeutics Inc
    GlycoMimetics Inc
    iTeos Therapeutics SA
    MandalMed Inc
    ...

    Buy now